Home › Ovarian Cancer › Florida › Fort Lauderdale
Ovarian Cancer clinical trials in Fort Lauderdale, FL
4 studies for Ovarian Cancer are looking for participants at sites in and around Fort Lauderdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Broward Health Medical Center, Fort Lauderdale
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Holy Cross Hospital, Fort Lauderdale
- Broward Health Medical Center, Fort Lauderdale
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
RecruitingPhase 4
- Broward Health, Fort Lauderdale
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecruitingPhase 3
- Broward Health Medical Center, Fort Lauderdale
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Fort Lauderdale
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Heart Failure6 studies
- Macular Degeneration5 studies
- Breast Cancer4 studies
- Multiple Myeloma3 studies
- Blood Cancers3 studies
- Chronic Kidney Disease3 studies
- Cardiovascular Disease3 studies
- Colon Cancer3 studies
- Colorectal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.